V. B. Damodaran; C. J. Fee. Protein PEGylation: An overview of chemistry and process considerations. European Pharmaceutical Review. 2010, s. 18–26. Dostupné online.
nih.gov
ncbi.nlm.nih.gov
J. V. Jokerst; T. Lobovkina; R. N. Zare; S. S. Gambhir. Nanoparticle PEGylation for imaging and therapy. Nanomedicine. 2011, s. 715–728. PMID21718180.
K. Knop; R. Hoogenboom; D. Fischer; U. S. Schubert. Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. Angewandte Chemie International Edition. 2010, s. 6288–6308. PMID20648499.
F. M. Veronese; A. Mero. The impact of PEGylation on biological therapies. BioDrugs. 2008, s. 315–329. PMID18778113.
M. R. Sherman; M. G. Saifer; F. Perez-Ruiz. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Advanced Drug Delivery Reviews. 2008-03-01, s. 59–68. PMID17826865.
F. M. Veronese; J. M. Perez-Ruiz. Introduction and overview of peptide and protein pegylation. Advanced Drug Delivery Reviews. 2002, s. 453–456. PMID12052707.
P. Milla; F. Dosio. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Current Drug Metabolism. 2012-01-13, s. 105–119. PMID21892917.
Daniel Balazs; W. T. Godbey. Liposomes for Use in Gene Delivery. Journal of Drug Delivery. 2010-10-29, s. 326497. PMID21490748.
G. Pasu; F. M. Veronese. State of the art in PEGylation: The great versatility achieved after forty years of research. Journal of Controlled Release. 2012, s. 461–472. PMID22094104.
Sinéad M. Ryan; Giuseppe Mantovani; Xuexuan Wang; David M. Haddleton; David J. Brayden. Advances in PEGylation of important biotech molecules: Delivery aspects. Expert Opinion on Drug Delivery. 2008, s. 371–383. PMID18426380.
F. Kawai. Microbial degradation of polyethers. Applied Microbiology and Biotechnology. 2002, s. 30–38. PMID11831473.
F. M. Veronese. Peptide and protein PEGylation: A review of problems and solutions. Biomaterials. 2001, s. 405–417. PMID11214751.
